Evommune

Performance

About Evommune

Evommune is a clinical-stage biotechnology company focused on discovering and developing novel therapies to treat immune-mediated chronic inflammatory diseases. The company emphasizes targeting root causes of inflammation through leading-edge science and maintains a pipeline of differentiated product candidates for chronic inflammatory conditions. Its programs include agents such as MRGPRX2 antagonists and IL-18 fusion proteins, with developments and clinical trials advancing to address unmet medical needs in inflammatory diseases.